About Us
Imagine Biotech has brought together a diverse and experienced team of PhDs in Pharmacology, CMC Experts, Computational Biologists, and Business Professionals who are collectively passionate about changing the drug discovery paradigm. Our company emerged from extensive involvement investing in startups and conducting due diligence projects.
Recognizing the significance of recent breakthroughs in AI and machine learning, we bring predictive capabilities in protein folding, early identification of latent issues and biotech failures, leading to more efficient investor capital allocation.
​
This team boasts a formidable track record of supporting biotech startups and conducting meticulous due diligence initiatives prior to starting this company.
​
​
Meet The Team
CEO & Co-Founder
Michael Savvides,
(MSc Eng | MBA)
Entrepreneur and investor, bringing an incredibly diverse international corporate and startup experience. Previously co-founding tech startups and healthcare businesses, with a successful company exit and liquidity event. Holding a Master of Science in Engineering and an MBA. Michael helped build and scale a high complexity laboratory business across 3 states in the USA, taking on a Vice President Role.
COO & Co-Founder
Dr. Joseph F. Nowoslawski (MD)
Dr. Nowoslawski, a highly experienced medical doctor and healthcare executive, holds degrees in Biology and Medicine, founded American Hospital Services Group (AHSG), has extensive involvement in biotech venture capital investing, and maintains various memberships in medical and science organizations while also contributing to philanthropic fundraising projects in Salt Lake City.
Advisor | Computational Biology
Dr. Karnati Konda Reddy, (Ph.D)
Proficient in Structural Bioinformatics, Machine Learning, Molecular Modelling, and Bimolecular Simulations, implementing emerging technologies. Authored more than 20 research articles in peer-reviewed journals and received multiple federal grants.
​
​
​
​
Avisor | Clinical Pharmacologist
Dr. Kash Yellepeddi, (Ph.D | RPh | DABCP)
A Ph.D. researcher from Texas A&M University specializes in nanotech anti-cancer drugs, holds Clinical Pharmacologist certification, and has affiliations with the university's medical and pharmacy schools. With industry experience at Sanofi and Nektar Therapeutics, they have numerous publications, a U.S. patent, and a successful funding history.
​​​​
​
​
Advisor | Expert Toxicologist & Director of Infusion
Chris Slater (MS)
​
A seasoned toxicologist with over 30 years of experience in non-clinical research. He has worked in human and veterinary pharmaceuticals at Hoffmann-La Roche, Merial Limited, and in contract research at SNBL USA, Experimur, and Charles River Labs. Supporting numerous companies with IND study design, monitoring, data interpretation, and regulatory filings. He has also helped expand CRO offerings.
Advisor | Chemistry, Manufacturing & Controls
Dr. Robert Sullivan (Ph.D)
Robert is a 20+ year drug development executive skilled in leading from research to clinical trials, optimizing manufacturing processes, and achieving regulatory compliance. His achievements include guiding the development of the company's first biotech asset and streamlining manufacturing for successful FDA approvals.
​
​
​
Advisor | Chemistry, Manufacturing & Controls
Dr. Gaylen M.Zentner (PhD)
Dr. Gaylen Zentner is a pharmaceutical expert with over 40 years of experience in Chemistry, Manufacturing & Controls (CMC), specializing in advanced drug delivery systems, solubilization, and bioavailability enhancement.
​
Advisor | Global Clinical Drug Development
Nadia Noorzai (CCRP)
With over two decades in global clinical drug development, Nadia has advanced from a research associate to senior management, spanning pharmaceuticals to biotech startups, including significant contributions at Amgen and recently at BeiGene, focusing on hematology. She is educated in chemistry and biology (BSc, University of Denver) and holds an MBA from Southern New Hampshire University.
Advisor | Emergency Medicine
Dr. Ksenya Badashova (MD | MBA)
Dr. Badashova, is a practicing medical physician with an interest in Pharmacogenomics and AI powered solutions in healthcare. Published in Medical Academia and Medical Business Publications. She completed her bachelors in sciences at UCLA, medical degree at Penn State, and a Masters in Business Administration at GW.
​​
​
​
​
Advisor | Biotech Investor & Incubation Hub
David Yazdi
David, a science-driven entrepreneur, founded Filtrous to empower researchers with top-quality lab consumables. He leads Abda Labs, dedicated to transformative medical research, and established Colab Haus, a thriving scientific incubator where visionaries and innovators come together.​​​
​
​
Advisor | Biotech Venture Capital Senior Associate
Doug Sills
Doug, an Associate at Venture Capital firm, brings experience from CVS Health and MDT Holdings in IT pharmacy operations and corporate
restructuring consulting. He's also skilled in sourcing debt capital for middle-market companies and has early-stage venture capital experience with Moonshots Capital.
​
Advisor | Biotech Head of Technical Operations
Eric Kozial
Eric Kozial, currently Senior Director of Technical Operations at Provention Bio (a Sanofi Company since August 2021), brings extensive experience in pharmaceuticals and scientific industries. Previously, they held roles at Ligand Pharmaceuticals, Astellas Pharma, InSource Diagnostics, Shimadzu Scientific Instruments, and Charles River Laboratories.